A review on various targeted anticancer therapies.

Targeted Oncology
Junjie LiYicheng Ni

Abstract

Translational oncology aims to translate laboratory research into new anticancer therapies. Contrary to conventional surgery, chemotherapy, and radiotherapy, targeted anticancer therapy (TAT) refers to systemic administration of drugs with particular mechanisms that specifically act on well-defined targets or biologic pathways that, when activated or inactivated, may cause regression or destruction of the malignant process, meanwhile with minimized adverse effects on healthy tissues. In this article, we intend to first give a brief review on various known TAT approaches that are deemed promising for clinical applications in the current trend of personalized medicine, and then we will introduce our newly developed approach namely small molecular sequential dual targeting theragnostic strategy as a generalized class of TAT for the management of most solid malignancies, which, after optimization, is expected to help improve overall cancer treatability and curability.

References

Mar 18, 1999·European Journal of Nuclear Medicine·C A HoefnagelM R Vieira
May 10, 2000·The Oncologist·G McMahon
Jan 30, 2002·Trends in Molecular Medicine·Michael L LinenbergerIrwin D Bernstein
Mar 1, 2002·The New England Journal of Medicine·Hagop KantarjianUNKNOWN International STI571 CML Study Group
Dec 10, 2002·Science·G ManningS Sudarsanam
Jan 15, 2003·Annual Review of Medicine·Margaret von MehrenLouis M Weiner
Jun 10, 2003·Breast Cancer Research : BCR·Johann S de BonoEric K Rowinsky
Aug 27, 2003·Gan to kagaku ryoho. Cancer & chemotherapy·Rumiko OkamotoTsuneo Sasaki
Oct 7, 2003·Oncogene·Sylvie MénardElda Tagliabue
Oct 11, 2003·Biotechnology Advances·A FunaroF Malavasi
Dec 6, 2003·Cancer Chemotherapy and Pharmacology·Philipp le CoutreEberhard Schleyer
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel J DeAngelo, Jerome Ritz
Feb 3, 2004·Current Pharmaceutical Design·Giampaolo TortoraFortunato Ciardiello
May 1, 2004·The New England Journal of Medicine·Mark R Green
Nov 19, 2004·Nature·Charles Sawyers
Dec 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel J Hicklin, Lee M Ellis
Dec 21, 2004·Expert Review of Anticancer Therapy·Mark A Pearson, Doriano Fabbro
Feb 16, 2005·Nature Biotechnology·Miles A FabianDavid J Lockhart
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shaoliang ChenDian Wen Ju
Mar 25, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angela J ManthaJim Dimitroulakos
Apr 1, 2005·International Journal of Cancer. Journal International Du Cancer·Liangli ZhaoBruce C Baguley
Jun 30, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ronald E Weiner, Mathew L Thakur
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Jul 19, 2005·Investigative Radiology·Yicheng NiGuy Marchal
Sep 8, 2005·Journal of the National Cancer Institute·Leslie Harris O'Hanlon
Sep 10, 2005·Nature Biotechnology·Gregory P Adams, Louis M Weiner
Jan 21, 2006·Nature Reviews. Drug Discovery·David SchramaJürgen C Becker
Feb 2, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Yicheng NiGuy M Bormans
Mar 25, 2006·Expert Opinion on Pharmacotherapy·Pier Paolo PiccalugaMichele Baccarani
Aug 22, 2006·Lancet·Peter Boyle
Sep 21, 2006·Bioconjugate Chemistry·Rameshwer ShuklaJames R Baker
Oct 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mihaela GinjJean Claude Reubi
Jan 30, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Martijn van EssenDik J Kwekkeboom

❮ Previous
Next ❯

Citations

Sep 13, 2013·Therapeutic Delivery·Kyrillus S Shohdy, Ahmad Samir Alfaar
May 28, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·F CornelisN Grenier
Jul 28, 2013·Journal of Vascular and Interventional Radiology : JVIR·Nadine Abi-JaoudehBradford J Wood
Jun 1, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Nan YaoJian Zhang
Jan 24, 2013·Proteomics. Clinical Applications·Kenneth D ColeLili Wang
Mar 19, 2016·Medicinal Research Reviews·Chin S KueHong B Lee
Dec 30, 2014·Biochimica Et Biophysica Acta·Hui DengJingde Zhu
Nov 25, 2016·European Journal of Mass Spectrometry·Sara D'AroncoMarco Agostini
Jun 16, 2018·Dalton Transactions : an International Journal of Inorganic Chemistry·Chilaluck C KonkankitJustin J Wilson
Dec 24, 2018·Chemical Communications : Chem Comm·Montserrat TerrazasModesto Orozco
May 26, 2021·European Journal of Medicinal Chemistry·Xue LiZhengyu Jiang
May 16, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jong Bong LeePavel Gershkovich
Aug 14, 2018·Bioconjugate Chemistry·Zhengyang JiangKevin Burgess
Apr 26, 2018··Vladimir N. KurlovElena E. Mukhina

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.